A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Sanofi partners with Synthekine in immunology race
Synthekine is teaming up with Sanofi in a $40 million-plus collaboration to develop IL-10 receptor agonists for autoimmune and inflammatory diseases. The cytokine-focused biotech will